Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Tian Zhang, Sarabjot Pabla, Felicia L. Lenzo, Jeffrey M. Conroy, Mary K. Nesline, Sean T. Glenn, Antonios Papanicolau-Sengos, Blake Burgher, Vincent Giamo, Jonathan Andreas, Yirong Wang, Wiam Bshara, Katherine G. Madden, Keisuke Shirai, Konstantin Dragnev, Laura J. Tafe, Rajan Gupta, Jason Zhu, Matthew Labriola, Shannon McCall, Daniel J. George, Pooja Ghatalia, Farshid Dayyani, Robert Edwards, Michelle S Park, Rajbir Singh, Robin Jacob, Saby George, Bo Xu, Matthew Zibelman, Razelle Kurzrock & Carl Morrison. (2020) Proliferative potential and response to nivolumab in clear cell renal cell carcinoma patients. OncoImmunology 9:1.
Read now
Read now
Zhun Wang, Hui Xie, Linpei Guo, Qiliang Cai, Zhiqun Shang, Ning Jiang & Yuanjie Niu. (2017) Prognostic and clinicopathological value of Ki-67/MIB-1 expression in renal cell carcinoma: a meta-analysis based on 4579 individuals. Cancer Management and Research 9, pages 679-689.
Read now
Read now
Thomas Weber, Matthias Meinhardt, Stefan Zastrow, Andreas Wienke, Kati Erdmann, Jörg Hofmann, Susanne Fuessel & Manfred P Wirth. (2014) Stage-dependent prognostic impact of molecular signatures in clear cell renal cell carcinoma. OncoTargets and Therapy 7, pages 645-654.
Read now
Read now
Articles from other publishers (16)
Tong Zhang, Ying Ming, Jingxu Xu, Ke Jin, Chencui Huang, Mingguang Duan, Kaiguo Li, Yuanwei Liu, Yonghui Lv, Jie Zhang & Zhaoqin Huang. (2023) Radiomics and Ki-67 index predict survival in clear cell renal cell carcinoma. The British Journal of Radiology.
Crossref
Crossref
Minne Line Mikkelsen, Niels Marcussen & Maj Rabjerg. (2021) Surgically induced ischemia has no impact on protein expression levels of HIF‐1α and related biomarkers in renal cell carcinoma. APMIS 129:9, pages 535-547.
Crossref
Crossref
Florent Petitprez, Mira Ayadi, Aurélien de Reyniès, Wolf H. Fridman, Catherine Sautès-Fridman & Sylvie Job. (2021) Review of Prognostic Expression Markers for Clear Cell Renal Cell Carcinoma. Frontiers in Oncology 11.
Crossref
Crossref
Anudeep Kaur, Lovedeep Singh, Saweta Garg, Harmanpreet Kaur, Nirmal Singh & Rajbir Bhatti. (2020) Involvement of Oxidative Stress and Nerve Growth Factor in Behavioral and Biochemical Deficits of Experimentally Induced Musculoskeletal Pain in Mice: Ameliorative Effects of Heraclin. Journal of Molecular Neuroscience 71:2, pages 347-357.
Crossref
Crossref
Anders Berglund, Ernest K. Amankwah, Young‐Chul Kim, Philippe E Spiess, Wade J. Sexton, Brandon Manley, Hyun Y. Park, Liang Wang, Jad Chahoud, Ratna Chakrabarti, Chang D. Yeo, Hung N. Luu, Giuliano D. Pietro, Alexander Parker & Jong Y. Park. (2020) Influence of gene expression on survival of clear cell renal cell carcinoma. Cancer Medicine 9:22, pages 8662-8675.
Crossref
Crossref
Zhun Wang, Shuanghe Peng, Ning Jiang, Aixiang Wang, Shuguang Liu, Hui Xie, Linpei Guo, Qiliang Cai & Yuanjie Niu. (2017) Prognostic and clinicopathological value of p53 expression in renal cell carcinoma: a meta-analysis. Oncotarget 8:60, pages 102361-102370.
Crossref
Crossref
Chengquan Ma, Bingxin Lu & Erlin Sun. (2017) Clinicopathological and prognostic significance of survivin expression in renal cancer patients: a meta-analysis. Postgraduate Medical Journal 93:1098, pages 186-192.
Crossref
Crossref
Yongpeng Xie, Luyao Chen, Xin Ma, Hongzhao Li, Liangyou Gu, Yu Gao, Yang Fan, Yu Zhang & Xu Zhang. (2017) Prognostic and clinicopathological role of high Ki-67 expression in patients with renal cell carcinoma: a systematic review and meta-analysis. Scientific Reports 7:1.
Crossref
Crossref
Maj Rabjerg, Barbara Guerra, Aida Oliván-Viguera, Minne Line Nedergaard Mikkelsen, Ralf Köhler, Olaf-Georg Issinger & Niels Marcussen. (2016) Nuclear localization of the CK2α-subunit correlates with poor prognosis in clear cell renal cell carcinoma. Oncotarget 8:1, pages 1613-1627.
Crossref
Crossref
Chaohui Xiong, Haipeng Liu, Zexin Chen, Yunxian Yu & Chaozhao Liang. (2016) Prognostic role of survivin in renal cell carcinoma: A system review and meta-analysis. European Journal of Internal Medicine 33, pages 102-107.
Crossref
Crossref
Yongpeng Xie, Xin Ma, Liangyou Gu, Hongzhao Li, Luyao Chen, Xintao Li, Yu Gao, Yang Fan, Yu Zhang, Yuanxin Yao & Xu Zhang. (2016) Prognostic and Clinicopathological Significance of Survivin Expression in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. Scientific Reports 6:1.
Crossref
Crossref
Laura-Maria Krabbe, Vitaly Margulis & Yair Lotan. (2016) Prognostic Role of Cell Cycle and Proliferative Markers in Clear Cell Renal Cell Carcinoma. Urologic Clinics of North America 43:1, pages 105-118.
Crossref
Crossref
Brett Delahunt, Hemamali Samaratunga & Diane N. Kenwright. (2016) Histologic prognostic markers for renal cell neoplasia. Diagnostic Histopathology 22:2, pages 65-72.
Crossref
Crossref
Pan Li, Zhi-Tao Xiao, Todd A. Braciak, Qing-Jan Ou, Gong Chen & Fuat S. Oduncu. (2016) Association between Ki67 Index and Clinicopathological Features in Colorectal Cancer. Oncology Research and Treatment 39:11, pages 696-702.
Crossref
Crossref
Jennifer S. Carew, Claudia M. Espitia, Weiguo Zhao, Monica M. Mita, Alain C. Mita & Steffan T. Nawrocki. (2015) Targeting Survivin Inhibits Renal Cell Carcinoma Progression and Enhances the Activity of Temsirolimus. Molecular Cancer Therapeutics 14:6, pages 1404-1413.
Crossref
Crossref
Jun Wang & Rafia S. Al-Lamki. (2013) Tumor Necrosis Factor Receptor 2: Its Contribution to Acute Cellular Rejection and Clear Cell Renal Carcinoma. BioMed Research International 2013, pages 1-11.
Crossref
Crossref